siRNAs knock down hepatitis

Nature Medicine

Volumn 9, Issue 3, 2003, Pages 266-267

  Zamore, Phillip D ^a   Aronin, Neil ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE; RIBOZYME; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CELL DEATH; DRUG INFUSION; DRUG MECHANISM; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENE THERAPY; HEPATITIS; IMMUNITY; KNOCKOUT GENE; LIVER FUNCTION; LIVER INJURY; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; RNA TRANSCRIPTION; SHORT SURVEY;

ANIMALS; ANTIGENS, CD95; DISEASE MODELS, ANIMAL; HEPATITIS; HUMANS; MICE; MODELS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING;

ANIMALIA; MAMMALIA;

EID: 0037348211     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0303-266     Document Type: Short Survey

References (9)

1. Song, E. et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9, 347-351.
2. Elbashir, S.M., Lendeckel, W. & Tuschl, T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15, 188-200 (2001).
3. Plasterk, R.H. RNA silencing: the genome's immune system. Science 296, 1263-1265 (2002).
4. Pomerantz, R.J. RNA interference meets HIV-1: will silence be golden? Nat. Med. 8, 659-660 (2002).
5. Wajant, H. The Fas signaling pathway: more than a paradigm. Science 296, 1635-1636 (2002).
6. Zhang, H. et al. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat. Biotechnol. 18, 862-867 (2000).
7. Nakamoto, Y. et al. Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-Fas ligand antibody therapy. J. Exp. Med. 196, 1105-1111 (2002).
8. Ryo, K. el al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am. J. Gastroenterol. 95, 2047-2055 (2000).
9. Lenardo, M. et al. Mature T lymphocyte apoptosis-immune regulation In a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17, 221-253 (1999).